tiprankstipranks
Trending News
More News >
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market

Quince Therapeutics (QNCX) Financial Statements

Compare
873 Followers

Quince Therapeutics Financial Overview

Quince Therapeutics's market cap is currently $48.20M. The company's EPS TTM is $-0.34; its P/E ratio is ―; Quince Therapeutics is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -322.00K$ -175.00K$ -344.00K$ -332.00K
Operating Income$ -57.28M$ -34.62M$ -52.02M$ -90.32M$ -78.89M
EBITDA$ -56.55M$ -31.26M$ -52.02M$ -89.97M$ -78.56M
Net Income$ -56.83M$ -31.39M$ -51.66M$ -89.33M$ -76.85M
Balance Sheet
Cash & Short-Term Investments$ 40.78M$ 75.06M$ 90.18M$ 106.80M$ 133.82M
Total Assets$ 114.48M$ 167.90M$ 103.91M$ 133.23M$ 189.47M
Total Debt$ 14.81M$ 13.81M$ 453.00K$ 1.16M$ 208.00K
Net Debt$ 8.60M$ -6.94M$ -44.13M$ -68.56M$ -66.63M
Total Liabilities$ 84.33M$ 82.82M$ 3.32M$ 14.64M$ 17.20M
Stockholders' Equity$ 30.15M$ 85.08M$ 100.59M$ 118.59M$ 172.26M
Cash Flow
Free Cash Flow$ -32.16M$ -18.45M$ -44.17M$ -63.11M$ -50.87M
Operating Cash Flow$ -31.90M$ -18.29M$ -44.04M$ -62.93M$ -50.82M
Investing Cash Flow$ 21.91M$ -5.76M$ 18.00M$ 58.95M$ -52.43M
Financing Cash Flow$ -4.78M$ 143.00K$ 707.00K$ 6.81M$ 118.88M
Currency in USD

Quince Therapeutics Earnings and Revenue History

Quince Therapeutics Debt to Assets

Quince Therapeutics Cash Flow

Quince Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis